Mariarosa Carta
- Internal Medicine top 1%
-
- Atrial Fibrillation Management and Outcomes 4
- Hematology top 5%
- Emergency Medical Services top 5%
-
- Diabetes Management and Research 17
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 12
- Diabetes, Cardiovascular Risks, and Lipoproteins 5
-
- Acute Kidney Injury Research 6
-
- Sepsis Diagnosis and Treatment 6
-
- SARS-CoV-2 and COVID-19 Research 4
-
- Diabetes and associated disorders 4
- Co-authors
- Mario VigoA.W.A. LensingJ W ten CateAlberto CogoPaolo PrandoniA. RuolH.R. BüllerDario Casara
- Journals
- The Lancet (1 paper)SHILAP Revista de lepidopterología (1 paper)Clinica Chimica Acta (2 papers)
- Partner nations
- ItalyUnited StatesNetherlands
In The Last Decade
Mariarosa Carta
44 papers receiving 862 citations
Hit Papers
Peers
Comparison fields: 5 of 82
- Internal Medicine 474
- Cardiology and Cardiovascular Medicine 403
- Hematology 157
- Emergency Medical Services 94
- Critical Care and Intensive Care Medicine 64
Countries citing papers authored by Mariarosa Carta
This map shows the geographic impact of Mariarosa Carta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mariarosa Carta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mariarosa Carta more than expected).
Fields of papers citing papers by Mariarosa Carta
This network shows the impact of papers produced by Mariarosa Carta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mariarosa Carta. The network helps show where Mariarosa Carta may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mariarosa Carta, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 1 | |
| 2 | 2021 | 0 | |
| 3 | 2021 | 8 | |
| 4 | 2021 | 15 | |
| 5 | 2021 | 2 | |
| 6 | 2020 | 14 | |
| 7 | 2020 | 5 | |
| 8 | 2020 | 2 | |
| 9 | 2020 | 17 | |
| 10 | 2019 | 8 | |
| 11 | 2019 | 1 | |
| 12 | 2018 | 5 | |
| 13 | 2018 | 22 | |
| 14 | 2018 | 27 | |
| 15 | 2012 | 2 | |
| 16 | 2003 | 1 | |
| 17 | 2001 | 21 | |
| 18 | Determination of HbA1c in the presence of haemoglobin variants: comparison of three HPLC techniques. | 1997 | 4 |
| 19 | Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosisbreakdown → | 1992 | 468 |
| 20 | [Long-term sequelae of deep venous thrombosis of the legs. Experience with mesoglycan]. | 1991 | 2 |
About Mariarosa Carta
Mariarosa Carta is a scholar working on Endocrinology, Diabetes and Metabolism, Internal Medicine and Nephrology, having authored 48 papers that have together received 911 indexed citations. Recurring topics across this work include Diabetes Management and Research (17 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (12 papers), Acute Kidney Injury Research (6 papers), Sepsis Diagnosis and Treatment (6 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Atrial Fibrillation Management and Outcomes (4 papers) and Diabetes and associated disorders (4 papers). The work is most often cited by research in Internal Medicine (474 citations), Cardiology and Cardiovascular Medicine (403 citations) and Hematology (157 citations). Mariarosa Carta has collaborated with scholars based in Italy, United States and Netherlands. Frequent co-authors include Mario Vigo, A.W.A. Lensing, J W ten Cate, Alberto Cogo, Paolo Prandoni, A. Ruol, H.R. Büller, Dario Casara, Davide Giavarina and Graziella Bonetti. Their work appears in journals such as The Lancet, SHILAP Revista de lepidopterología and Clinica Chimica Acta.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.